Researchers are zeroing in on the ways SARS-CoV-2 damages and persists inside blood vessels, raising the risk for heart ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

Polypill treatment for cardiovascular disease prevention is of high value in a low-income, underserved population, according ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...

Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits beyond weight loss ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

The CASE-J trial enrolled 4728 patients, with a mean age of 63.8 years and a mean BMI of 24.6 kg/m 2, who were randomly assigned to either candesartan- or amlodipine-based treatment regimens.

For both reasons, each person’s treatment plan will be different. Read on to learn about the types of MS treatments available. Disease-modifying therapies (DMTs) can reduce the frequency and ...